Published in Cancer Weekly, February 12th, 2008
"During 2008, our primary focus will continue to be the advancement of our clinical pipeline," said Robert L. Kirkman, M.D., President and Chief Executive Officer of Oncothyreon. "We are committed to the rapid development of our product...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.